Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.15T
Market cap1.15T
Price-Earnings ratio
43.76
Price-Earnings ratio43.76
Dividend yield
0.53%
Dividend yield0.53%
Average volume
3.47M
Average volume3.47M
High today
$1,229.86
High today$1,229.86
Low today
$1,200.37
Low today$1,200.37
Open price
$1,211.65
Open price$1,211.65
Volume
2.08M
Volume2.08M
52 Week high
$1,249.45
52 Week high$1,249.45
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

As of today, Eli Lilly(LLY) shares are valued at $1,219.56. The company's market cap stands at 1.15T, with a P/E ratio of 43.76 and a dividend yield of 0.53%.

During the trading session on 2026-07-09, Eli Lilly(LLY) shares reached a daily high of $1,229.86 and a low of $1,200.37. At a current price of $1,219.56, the stock is +1.6% higher than the low and still -0.8% under the high.

Trading volume for Eli Lilly(LLY) stock has reached 2.08M, versus its average volume of 3.47M.

The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.

The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.

LLY News

Nasdaq 2h
Record Numbers of Americans Are on GLP-1 Drugs. That's Great News for This Stock.

Key Points More Americans than ever are using GLP-1 drugs. Eli Lilly recently rolled out an oral weight loss drug. 10 stocks we like better than Eli Lilly ›...

Record Numbers of Americans Are on GLP-1 Drugs. That's Great News for This Stock.
24/7 Wall St. 3h
Eli Lilly’s $400 Billion Surge Is Reshaping Big Pharma

Eli Lilly’s $400 Billion Surge Is Reshaping Big Pharma By Chris MacDonald Published Jul 9, 2:28PM EDT Quick Read LLY added $400 billion in market value over o...

Eli Lilly’s $400 Billion Surge Is Reshaping Big Pharma
24/7 Wall St. 5h
Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%

Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59% By David Beren Published Jul 9, 12:18PM EDT Quick Read OZEM holds Lilly at 16% and No...

Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%

Analyst ratings

84%

of 31 ratings
Buy
83.9%
Hold
9.7%
Sell
6.5%

More LLY News

TipRanks 9h
Eli Lilly price target raised to $1,370 from $1,281 at Truist

Truist raised the firm’s price target on Eli Lilly (LLY) to $1,370 from $1,281 and keeps a Buy rating on the shares ahead of its Q2 results. The quarter could b...

TipRanks 10h
Eli Lilly to presents abstracts at 2026 AAIC on Kisunla trials

Eli Lilly (LLY) announced it will present 16 abstracts at the 2026 Alzheimer’s Association International Conference, AAIC,, July 12-15 in London. Three oral pre...

TipRanks 15h
Eli Lilly Stock Gets a Boost as Eczema Treatment Receives a Positive Recommendation in Canada

Eli Lilly’s (LLY) stock is getting a boost on an otherwise down day for markets as its drug to treat the skin condition eczema received a positive recommendatio...

The Motley Fool 23h
My Forever Portfolio: 5 Undervalued Stocks to Buy Now and Hold Forever

Parkev Tatevosian, CFA has positions in Amazon and Eli Lilly. The Motley Fool has positions in and recommends Amazon, Eli Lilly, and Taiwan Semiconductor Manufa...

My Forever Portfolio: 5 Undervalued Stocks to Buy Now and Hold Forever
Nasdaq 1d
Is It Too Late to Buy Eli Lilly?

Key Points Eli Lilly's Mounjaro and Zepbound are the leading drugs in the GLP-1 space. The company's GLP-1 success has resulted in a lofty valuation for the s...

Is It Too Late to Buy Eli Lilly?
Investor's Business Daily 1d
This Unlikely Growth Stock Is Breaking Out. It Has Nothing To Do With AI — Yet

Stocks To Watch: 14 Names Test And Tease New Buy Zones 7/08/2026 A barrage of stocks to watch like Eli Lilly and Deere, show promise, alongside reminders to ke...

This Unlikely Growth Stock Is Breaking Out. It Has Nothing To Do With AI — Yet
Nasdaq 1d
Prediction: Eli Lilly Stock Will Hit This Price by the End of 2026

Key Points Eli Lilly's new oral obesity drug, Foundayo, removes many of the barriers that have limited GLP-1 adoption, potentially expanding the addressable ma...

Prediction: Eli Lilly Stock Will Hit This Price by the End of 2026

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.